Morgan Stanley increases CSL price target for second time

SYDNEY: Morgan Stanley analysts have upped their price target for CSL as they move their… read more

Rapid testing company Ellume’s big biotech IPO still on table

SYDNEY: There’s at least one $600 million-plus biotech still testing the IPO waters in 2022…. read more

20 new senior healthcare executives sought for key roles

MELBOURNE: Twenty senior healthcare, aged and retirement village executive positions remain open. New positions listed… read more

EBOS buyout cleared by competition regulator earlier today

SYDNEY: The competition regular will not oppose EBOS’s $1.2bn buyout of Pacific Health Group….

To

read more